Cargando…
Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein
Tunicamycin has different effects on the glycosylation of the two envelope glycoproteins of mouse hepatitis virus (MHV), a coronavirus. Unlike envelope glycoproteins of other viruses, the transmembrane glycoprotein El is glycosylated normally in the presence of tunicamycin. This suggests that glycos...
Autores principales: | Holmes, Kathryn V., Doller, Elizabeth W., Sturman, Lawrence S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130623/ https://www.ncbi.nlm.nih.gov/pubmed/7314449 http://dx.doi.org/10.1016/0042-6822(81)90115-X |
Ejemplares similares
-
The novel glycoproteins of coronaviruses
por: Sturman, Lawrence, et al.
Publicado: (1985) -
Characterization of a coronavirus(): II. Glycoproteins of the viral envelope: Tryptic peptide analysis
por: Sturman, Lawrence S., et al.
Publicado: (1977) -
Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype.
por: Kramer, R., et al.
Publicado: (1995) -
Effect of tunicamycin and monensin on biosynthesis, transport, and maturation of bovine herpesvirus type-1 glycoproteins
por: Van Drunen Littel-Van Den Hurk, Sylvia, et al.
Publicado: (1985) -
Coronavirus glycoprotein E1, a new type of viral glycoprotein()
por: Niemann, H., et al.
Publicado: (1981)